Literature DB >> 24308973

Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice.

Chie Kurashige1, Kanako Hosono, Hiromi Matsuda, Kazutake Tsujikawa, Hirotsugu Okamoto, Masataka Majima.   

Abstract

Receptor activity-modifying protein 1 (RAMP1) forms a complex with calcitonin receptor-like receptor (CLR) to produce the receptor for calcitonin gene-related peptide (CGRP). CGRP, a 37-aa neuropeptide, is widely distributed in neuronal tissues and exerts its biological effects via CLR/RAMP1; however, the pathophysiological roles of CLR/RAMP1 remain to be clarified. To study the functions of CLR/RAMP1, we generated RAMP1-knockout (RAMP1(-/-)) mice. Compared with those of wild-type (WT) mice, wound healing and wound-induced angiogenesis were significantly suppressed in RAMP1(-/-) mice, with reduced expression of vascular endothelial growth factor (VEGF)-A. Formation of the lymphatic vessels that drain interstitial fluids was also suppressed in RAMP1(-/-) mice, with reduced expression of VEGF-C and VEGFR-3 in wound granulation tissues. RAMP1 was expressed in endothelial cells (ECs) in the preexisting skin blood vessels, but was not observed in ECs in newly formed blood or lymphatic vessels. Macrophages in the wound granulation tissues expressed RAMP1 and produced substantial amounts of VEGF-C in response to CGRP in vitro. RAMP1(-/-) bone marrow chimeric mice showed delayed wound healing with reduced angiogenesis/lymphangiogenesis in wound granulation tissues. These findings suggest that RAMP1 plays a crucial role in wound healing and wound-induced angiogenesis and lymphangiogenesis and that it is a promising target for controlling angiogenesis and lymphangiogenesis.

Entities:  

Keywords:  CD31; VEGFR-3; calcitonin gene-related peptide; macrophages; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 24308973     DOI: 10.1096/fj.13-238998

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  17 in total

Review 1.  Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

Authors:  Debbie L Hay; Augen A Pioszak
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

Review 2.  Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation.

Authors:  Felipe A Pinho-Ribeiro; Waldiceu A Verri; Isaac M Chiu
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

3.  RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis.

Authors:  Seri Tsuru; Yoshiya Ito; Hiromi Matsuda; Kanako Hosono; Tomoyoshi Inoue; Shuji Nakamoto; Chie Kurashige; Toshiaki Mishima; Kazutake Tsujikawa; Hirotsugu Okamoto; Masataka Majima
Journal:  Lab Invest       Date:  2020-01-07       Impact factor: 5.662

4.  Sensory Neurotransmitter Calcitonin Gene-Related Peptide Modulates Tumor Growth and Lymphocyte Infiltration in Oral Squamous Cell Carcinoma.

Authors:  Lisa A McIlvried; Megan A Atherton; Nicole L Horan; Tori N Goch; Nicole N Scheff
Journal:  Adv Biol (Weinh)       Date:  2022-04-07

Review 5.  Dawn of a New RAMPage.

Authors:  D Stephen Serafin; Natalie R Harris; Natalie R Nielsen; Duncan I Mackie; Kathleen M Caron
Journal:  Trends Pharmacol Sci       Date:  2020-02-27       Impact factor: 14.819

Review 6.  Neuronal regulation of immunity: why, how and where?

Authors:  Maya Schiller; Tamar L Ben-Shaanan; Asya Rolls
Journal:  Nat Rev Immunol       Date:  2020-08-18       Impact factor: 53.106

Review 7.  Cutaneous innervation in impaired diabetic wound healing.

Authors:  Nicole C Nowak; Daniela M Menichella; Richard Miller; Amy S Paller
Journal:  Transl Res       Date:  2021-05-23       Impact factor: 10.171

8.  Calcitonin gene‑related peptide induces IL‑6 expression in RAW264.7 macrophages mediated by mmu_circRNA_007893.

Authors:  Tian Deng; Lan Yang; Zhichao Zheng; Yuanjing Li; Wen Ren; Caijuan Wu; Lvhua Guo
Journal:  Mol Med Rep       Date:  2017-10-12       Impact factor: 2.952

9.  Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice.

Authors:  Kanako Hosono; Risa Isonaka; Tadashi Kawakami; Shuh Narumiya; Masataka Majima
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 10.  An Evidence-Based Review of Fremanezumab for the Treatment of Migraine.

Authors:  Ivan Urits; Gavin Clark; Daniel An; Bredan Wesp; Rebecca Zhou; Ariunzaya Amgalan; Amnon A Berger; Hisham Kassem; Anh L Ngo; Alan D Kaye; Rachel J Kaye; Elyse M Cornett; Omar Viswanath
Journal:  Pain Ther       Date:  2020-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.